No Data
No Data
December 5th [Today's investment strategy]
[Fisco Selected Stocks] 【Material Stocks】 Japan Creation Group <7814> 445 yen (12/4) engages in printing, sales promotion, and original goods development, etc. Announced it will implement a share buyback of 0.6 million shares, equivalent to 1.27% of the total issued shares, with a maximum amount of 0.267 billion yen. On December 5, a purchase commission will be made in the Tokyo Stock Exchange's off-market share buyback trade (ToSTNeT-3). As of December 4, 2024, the company holds 3.91 million 6240 shares. 【Emerging Market
Keep an eye on Keyper Giken and V Cube.
In the U.S. stock market on the 4th, the dow jones industrial average rose by 308.51 points to 45,014.04, the nasdaq composite index increased by 254.21 points to 19,735.12, and the chicago nikkei 225 futures were up 355 yen compared to the Osaka daytime market at 39,625 yen. The exchange rate was 1 dollar = 150.60-70 yen. In today's Tokyo market, the domestic same-store sales for November recovered to a positive with a 4.7% increase from a 7.3% decrease in October for World <3612>, and the same-store sales for the existing store operations of Key Per Lab increased by 9.3%.
Kumiai Chemical, 24/10 upward revision, operating profit 11.5 billion yen ← 10 billion yen
Kumiai Chemical Industry Co., Ltd. <4996> announced a revision to its financial estimates for the fiscal year ending October 2024. Revenue has been revised upwards from 155 billion yen to 161 billion yen, and operating profit has increased from 10 billion yen to 11.5 billion yen. In the agrochemicals and agricultural-related business, shipments of agrochemicals for overseas markets, including the herbicide "Axive", have increased, leading to a forecast of increased revenue and operating profit compared to the revised estimates disclosed on June 4, 2024. 【Positive Assessment】 <4996> Kumiai Chemical Industry Co., Ltd. Revision | 【Hold】 <4
Daisan: Confirmation letter
Daisan: Interim report - 51st period (2024/04/21 - 2025/04/20)
Daisan: Supplementary explanation of financial results for the 2nd quarter (interim period) of the fiscal year ending April 2025